These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22158111)

  • 1. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
    Azegami T; Sasamura H; Hayashi K; Itoh H
    Hypertens Res; 2012 May; 35(5):492-9. PubMed ID: 22158111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candesartan and progression of preglomerular lesions in N(G)-nitro-L-arginine methyl ester hypertensive rats.
    Casellas D; Benahmed S; Artuso A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S230-3. PubMed ID: 9892169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats.
    Rivera-Jardón FF; Castro-Moreno P; Figueroa-Guillén ES; Gallardo-Ortíz IA; Godínez-Hernández D; Ibarra-Barajas M
    Proc West Pharmacol Soc; 2009; 52():47-9. PubMed ID: 22128421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II pressor response in the L-NAME-induced hypertensive pithed rat: role of the AT1 receptor.
    Figueroa-Guillén ES; Castro-Moreno P; Rivera-Jardón FF; Gallardo-Ortiz IA; Ibarra-Barajas M; Godínez-Hernández D
    Proc West Pharmacol Soc; 2009; 52():54-6. PubMed ID: 22128423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive influence of AT(1) receptor antagonism upon the impaired celiprolol-induced vasodilatation in aorta from spontaneously hypertensive rats.
    Sauvaget F; Mallem MY; Bucas V; Gogny M; Desfontis JC; Noireaud J
    Eur J Pharmacol; 2010 Oct; 644(1-3):169-75. PubMed ID: 20637193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
    Demeilliers B; Mimran A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
    Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
    Takemori K; Ishida H; Ito H
    Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular and tubular function during AT1 receptor blockade in pigs with neonatal induced partial ureteropelvic obstruction.
    Eskild-Jensen A; Thomsen K; Rungø C; Ferreira LS; Paulsen LF; Rawashdeh YF; Nyengaard JR; Nielsen S; Djurhuus JC; Frøkiaer J
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F921-9. PubMed ID: 17132866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade.
    Vanecková I; Kopkan L; Husková Z; Vanourková Z; Schejbalová S; Cervenka L; Kramer HJ
    Kidney Blood Press Res; 2007; 30(1):38-44. PubMed ID: 17237618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.